Stephen Wargacki - Mar 9, 2024 Form 4/A - Amendment Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role: Chief Science Officer
Signature: /s/ Lori Braender, as Attorney-In-Fact
Stock symbol: AQST
Transactions as of: Mar 9, 2024
Transactions value $: -$95,184
Form type: 4/A - Amendment
Date filed: 10/2/2024, 02:15 PM
Date Of Original Report: Mar 12, 2024
Previous filing: Aug 9, 2023
Next filing: May 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AQST	Common Stock	Tax liability	-$95.2K	-19.5K	-6.94%	$4.88	261K	Mar 9, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 .

Content

Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 .